ASH: PET Helps Tailor Therapy in Limited-Stage DLBCL

MONDAY, Dec. 9, 2019 -- Positron emission tomography (PET)-directed therapy results in excellent outcomes for patients with stage I/II diffuse large B-cell lymphoma (DLBCL), according to a study presented at the annual meeting of the American...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news